Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy M Shefner

Showing results (31-40 of 105) with videos related to

Pageof 11
Sort By:
Annals of Neurology|December 26, 2015
ReplySeward B Rutkove, Jeremy M Shefner, Robert Bowser, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 20, 2013
A study to evaluate safety and tolerability of repeated doses of tirasemtiv in patients with amyotrophic lateral sclerosisJeremy M Shefner, Mary Lou Watson, Lisa Meng, et al.
Annals of Neurology|February 1, 2021
To Zoom or Not to Zoom: The Should I Travel Index Revisited during the Coronavirus Disease PandemicSeward B Rutkove, Jeremy M Shefner, Robert Bowser, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 12, 2017
Profile of medical care costs in patients with amyotrophic lateral sclerosis in the Medicare programme and under commercial insuranceLisa Meng, Amy Bian, Scott Jordan, et al.
The American Journal of Managed Care|April 26, 2018
Edaravone in the treatment of amyotrophic lateral sclerosis: efficacy and access to therapy - a roundtable discussionBenjamin Rix Brooks, James A Jorgenson, Barbara J Newhouse, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 30, 2018
ALS longitudinal studies with frequent data collection at home: study design and baseline dataSeward B Rutkove, Kristin Qi, Kerisa Shelton, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 20, 2023
Harmonized standard operating procedures for administering the ALS functional rating scale-revisedJeremy M Shefner, Tommy Bunte, Gale Kittle, et al.
Epidemiology (Cambridge, Mass.)|April 20, 2002
Lead exposure and amyotrophic lateral sclerosisFreya Kamel, David M Umbach, Theodore L Munsat, et al.
Neurology|July 8, 2016
Quantitative strength testing in ALS clinical trialsJeremy M Shefner, Dawei Liu, Melanie L Leitner, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 17, 2016
A randomized, placebo-controlled, double-blind phase IIb trial evaluating the safety and efficacy of tirasemtiv in patients with amyotrophic lateral sclerosisJeremy M Shefner, Andrew A Wolff, Lisa Meng, et al.
Pageof 11

Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
Annals of Neurology|December 26, 2015
ReplySeward B Rutkove, Jeremy M Shefner, Robert Bowser, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 20, 2013
A study to evaluate safety and tolerability of repeated doses of tirasemtiv in patients with amyotrophic lateral sclerosisJeremy M Shefner, Mary Lou Watson, Lisa Meng, et al.
Annals of Neurology|February 1, 2021
To Zoom or Not to Zoom: The Should I Travel Index Revisited during the Coronavirus Disease PandemicSeward B Rutkove, Jeremy M Shefner, Robert Bowser, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 12, 2017
Profile of medical care costs in patients with amyotrophic lateral sclerosis in the Medicare programme and under commercial insuranceLisa Meng, Amy Bian, Scott Jordan, et al.
The American Journal of Managed Care|April 26, 2018
Edaravone in the treatment of amyotrophic lateral sclerosis: efficacy and access to therapy - a roundtable discussionBenjamin Rix Brooks, James A Jorgenson, Barbara J Newhouse, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 30, 2018
ALS longitudinal studies with frequent data collection at home: study design and baseline dataSeward B Rutkove, Kristin Qi, Kerisa Shelton, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 20, 2023
Harmonized standard operating procedures for administering the ALS functional rating scale-revisedJeremy M Shefner, Tommy Bunte, Gale Kittle, et al.
Epidemiology (Cambridge, Mass.)|April 20, 2002
Lead exposure and amyotrophic lateral sclerosisFreya Kamel, David M Umbach, Theodore L Munsat, et al.
Neurology|July 8, 2016
Quantitative strength testing in ALS clinical trialsJeremy M Shefner, Dawei Liu, Melanie L Leitner, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 17, 2016
A randomized, placebo-controlled, double-blind phase IIb trial evaluating the safety and efficacy of tirasemtiv in patients with amyotrophic lateral sclerosisJeremy M Shefner, Andrew A Wolff, Lisa Meng, et al.
Pageof 11